Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap
A primary investment of Rs 194.4 crore has been made
Pharmapack Europe recognizes excellence and innovation from exhibitors across connected devices, sustainability, supply chain logistics, route of administration, and packaging innovation, as well from the wider industry for patient-centric design and eco-design
The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe Covid-19
Subscribe To Our Newsletter & Stay Updated
